-
Increasing cases of diabetes and obesity is driving the growth of the market
-
Growing Nonalcoholic steatohepatitis (NASH) affected population worldwide will also drive the market growth
-
Rising healthcare expenditure will also propel the market growth
-
Increasing launches of pipeline drugs will also contribute as a factor for the growth of this market
-
Lack of proper diagnostic technologies for Nonalcoholic steatohepatitis (NASH) will restrain the market growth
-
Less demand in the underdeveloped countries is another factor restraining the market growth
-
o Hospitals
-
o Clinics
-
o Homecare settings
-
In July 2019, Altimmune, Inc announced that they have acquired Spitfire Pharma, Inc along with their product candidate SP-1373 to treat non-alcoholic steatohepatitis (NASH). The main aim of the acquisition is to help the company to meet the requirement of the people for treatment of Nonalcoholic steatohepatitis (NASH). This acquisition will strengthen the company’s position in the market and will provide better treatment to their patients
-
In July 2019, InSphero AG launched their new 3D InSight Human Liver Disease Discovery Platform which is specially designed for the safety testing of nonalcoholic steatohepatitis drugs and nonalcoholic fatty liver disease. The main aim of this launch is to meet the increasing demand of research community for efficient and fast screening of the drug candidates
-
Current and future of global non-alcoholic steatohepatitis market outlook in the developed and emerging markets
-
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
-
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
-
The latest developments, market shares, and strategies that are employed by the major market players
-
All segmentation provided above in this report is represented at country level
-
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Market Analysis and Insights: Non-alcoholic Steatohepatitis Market Non-alcoholic Steatohepatitis Market By Drug Type (Vitamin E & Pioglitazone, Ocaliva, Elafibranor, Selonsertib & Cenicriviroc, Obeticholic acid, Others), Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), End User (Hospitals, Clinics, Homecare settings), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026Global non-alcoholic steatohepatitis market is set to witness healthy CAGR of 56.15% in the forecast period of 2019- 2026.
Increasing demand for NASH therapeutics and increasing presence of pipeline drugs are the factor for the growth.Download PDF Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-alcoholic-steatohepatitis-marketNonalcoholic steatohepatitis (NASH) is a kind of a non-alcoholic fatty liver disease (NAFLD) which usually occurs when fat is collected in the liver.
It usually causes inflammation and also damages the liver cell.
According to researchers, about 3 to 12 percentage of population in United States is suffering from nonalcoholic steatohepatitis.Market DriversIncreasing cases of diabetes and obesity is driving the growth of the marketGrowing Nonalcoholic steatohepatitis (NASH) affected population worldwide will also drive the market growthRising healthcare expenditure will also propel the market growthIncreasing launches of pipeline drugs will also contribute as a factor for the growth of this marketMarket Restraints Lack of proper diagnostic technologies for Nonalcoholic steatohepatitis (NASH) will restrain the market growthLess demand in the underdeveloped countries is another factor restraining the market growthSegmentation: Global Non-alcoholic Steatohepatitis MarketBy Drug Type o Vitamin E & Pioglitazone o Ocaliva o Obeticholic acid o Elafibranor o Selonsertib & Cenicriviroc o OthersBy Sales Channel o Hospital Pharmacy o Online Provider o Retail PharmacyBy Disease Cause o Hypertension o Heart Disease o High Blood Lipid o Type 2 Diabetes o ObesityEnd Usero Hospitalso Clinicso Homecare settingsBy GeographyNorth Americao U.S.o Canadao MexicoEuropeo Germanyo Italyo U.K.o Franceo Spaino Netherlandso Belgiumo Switzerlando Turkeyo Russiao Rest of EuropeAsia-Pacifico Japano Chinao Indiao South Koreao Australiao Singaporeo Malaysiao Thailando Indonesiao Philippineso Rest of Asia-PacificSouth Americao Brazilo Rest of South AmericaMiddle East and Africao South Africao Rest of Middle East and AfricaFor More Information or Query or Looking for Customization, Visit @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-non-alcoholic-steatohepatitis-marketKey Developments in the Market:In July 2019, Altimmune, Inc announced that they have acquired Spitfire Pharma, Inc along with their product candidate SP-1373 to treat non-alcoholic steatohepatitis (NASH).
This acquisition will strengthen the company’s position in the market and will provide better treatment to their patientsIn July 2019, InSphero AG launched their new 3D InSight Human Liver Disease Discovery Platform which is specially designed for the safety testing of nonalcoholic steatohepatitis drugs and nonalcoholic fatty liver disease.
The main aim of this launch is to meet the increasing demand of research community for efficient and fast screening of the drug candidatesCompetitive Analysis:Global non-alcoholic steatohepatitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The Global Biomarkers Market Report, with its deep industry analysis of the market, estimates the market size bifurcated into segments and regions.
The Biomarkers market share and growth, trends estimated at the end of 2027 give a fair idea of the new opportunities coming up in the market.
The detailed key player's profile and market share analysis give a better understanding of the competitors and their business strategies.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Biomarkers Market @ https://www.decisiondatabases.com/contact/download-sample-5313A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Biomarkers market.
The impact is closely studied in terms of production, import, export, and supply.The report covers the complete competitive landscape of the Worldwide Biomarkers market with company profiles of key players such as:Singulex, Inc.Signosis, Inc.Meso Scale Diagnostics, LLC.Biosims TechnologiesQiagen N.V.Merck & Co, Inc.ENZO Biochem, Inc.EKF Diagnostics Holdings, Inc.Bio-Rad Laboratories, Inc.Perkinelmer, Inc.Cisbio BioassaysWant to add more Company Profiles to the Report?
Global Biomarkers Market: Information By Product (Consumables, Services, Software), By Type (Safety Biomarkers, Validation Biomarkers, Efficacy Biomarkers), By Application (Diagnostics, Personalized Medicine, Drug Discovery and Development, Disease Risk Assessment) and By Disease Indication (Cancer, Neurological Disorders, Cardiovascular Disorders, Immunological Disorders, Others) - Forecast till 2027The global biomarkers market is expected to rise at a CAGR of 13.3% over the forecast period from 2016 to 2022, according to a new report from Market Research Future (MRFR).
Major players operating in the global biomarkers market are also assessed in the report to provide readers with a clear understanding of the competitive landscape of the market.Biomarkers are identifiers of diseases manifested within the body by the body’s natural reaction with the respective disease.
The global market for biomarkers has been mainly driven by the growing medical research sector around the world, including in developed countries such as France, the U.S., and Germany as well as emerging economies such as India, China, and Japan.The growing prevalence of communicable diseases as well as chronic noncommunicable diseases, such as cancer, has been vital for the global medical biomarkers market in the last few years.
This is likely to remain a key driver for the global biomarker market over the forecast period, as several countries have stepped up their efforts in the medical research sector due to the high profitability of the sector for the players involved in it.
The growing government expenditure in cancer research is likely to be a major driver for the global biomarker market over the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1941Segmentation:The global biomarkers market is segmented on the basis of type, indication, application, and region.The global biomarkers market has been segmented on the basis of type into predisposition biomarkers, diagnostic biomarkers, prognostic biomarkers, and predictive biomarkers.On the basis of indication, the biomarkers market is segmented into cancer, neurological disorders, cardiovascular disorders, immunological disorders, and others.On the basis of application, the biomarkers market is segmented into tests, therapies, drug discovery, drug formulation, and others.Regional Analysis:The global biomarkers market is segmented into North America, Europe, Asia Pacific, and the Middle East and Africa on the basis of region.North America is the dominant regional revenue generator in the global biomarkers market and is likely to remain a leading force over the forecast period, with the regional market expected to grow at a CAGR of 13.6% over the forecast period.
The strong presence of several leading players in the biomarkers market is likely to drive the market in North America.
According to IMARC Group’s latest report, titled “Oxidative Stress Assay Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”.
Looking forward, IMARC Group expects the global oxidative stress assay market to continue its moderate growth during the next five years.Oxidative stress is a health condition where excessive production of oxygen-derived free radicals within a cell or organism inhibits the antioxidant defenses.
It can damage proteins, lipids, and nucleic acid, further leading to the development of cancer, asthma, ischemia, diabetes, cardiovascular and neurodegenerative disorders.
It is diagnosed using various assays that provide valuable insights to healthcare researchers about the mechanisms and responses of the condition.Request for a free sample copy of this report: https://www.imarcgroup.com/oxidative-stress-assay-market/requestsampleMarket TrendsThe increasing consumption of tobacco and alcohol, along with rising air pollution levels, has led to an increase in oxidative stress among individuals, thereby driving the demand for oxidative stress assays.
Moreover, the increasing pathologic conditions and accelerating aging processes due to oxidative stress are also bolstering the product demand.
Several technological advancements have led to the emergence of high-content screening for drug discovery, thereby propelling the market growth.
The Global Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.Report includes a detailed analysis on value chain in order to provide a holistic view of the biomarkers market.
Value chain analysis comprises detailed evaluation of the roles of various players involved in the biomarkers industry, from raw material suppliers to end-users.Browse the complete Global Biomarkers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/5313-biomarkers-market-reportThe report also offers a competitive landscape of the overall market with company profiles of players such as:Singulex, Inc.Signosis, Inc.Meso Scale Diagnostics, LLC.Biosims TechnologiesQiagen N.V.Merck & Co, Inc.ENZO Biochem, Inc.EKF Diagnostics Holdings, Inc.Bio-Rad Laboratories, Inc.Perkinelmer, Inc.Cisbio BioassaysSEGMENTATIONS IN REPORT:Biomarkers Market By Product:ConsumablesServicesSoftwareBiomarkers Market By Type:Safety BiomarkersEfficacy BiomarkersValidation BiomarkersBiomarkers Market By Disease Indication:CancerCardiovascular DisordersNeurological DisordersImmunological DisordersOther DiseasesBiomarkers Market By Applications:Diagnostics DevelopmentDrug Discovery and DevelopmentPersonalized MedicineDisease Risk AssessmentOther ApplicationsBiomarkers Market By Geography:North AmericaEuropeAsia PacificRest of the WorldDownload Free Sample Report of Global Biomarkers Market @ https://www.decisiondatabases.com/contact/download-sample-5313The Global Biomarkers Market has been exhibited in detail in the following chapters –Chapter 1 Biomarkers Market PrefaceChapter 2 Executive SummaryChapter 3 Biomarkers Industry AnalysisChapter 4 Biomarkers Market Value Chain AnalysisChapter 5 Biomarkers Market Analysis By ProductChapter 6 Biomarkers Market Analysis By TypeChapter 7 Biomarkers Market Analysis By Disease IndicationChapter 8 Biomarkers Market Analysis By ApplicationsChapter 9 Biomarkers Market Analysis By GeographyChapter 10 Competitive Landscape Of Biomarkers CompaniesChapter 11 Company Profiles Of Biomarkers IndustryPurchase the complete Global Biomarkers Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-5313Other Reports by DecisionDatabases.com:Global Cancer Biomarkers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Central Nervous System Biomarkers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Cardiac Biomarkers Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
